CYTO
Altamira Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · BM
$0.30
+0.00%Leverage
- Debt / equity
- -1.90x
- Net debt / equity
- -1.87x
- Debt / assets
- 0.56x
- Debt / EBITDA
- 1.72x
- Net debt / EBITDA
- 1.69x
Liquidity & coverage
- Current ratio
- 0.32x
- Quick ratio
- 0.27x
- Cash ratio
- 0.01x
- Interest coverage
- -3.06x
- EBITDA / interest
- 3.46x
- Working capital
- -$4.5M
Cash & dividend
- FCF / debt
- -3.12x
- Cash flow / debt
- -3.12x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2023